These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 35446931

  • 1. Clinical and Radiographic Outcomes of Dental Implants in Patients Treated With Antiresorptive Drugs: A Consecutive Case Series.
    Otto S, Schnoedt EM, Troeltzsch M, Kaeppler G, Aljohani S, Liebermann A, Fliefel R.
    J Oral Implantol; 2023 Feb 01; 49(1):39-45. PubMed ID: 35446931
    [Abstract] [Full Text] [Related]

  • 2. Medication-Related Osteonecrosis of the Jaw Around Dental Implants: Implant Surgery-Triggered or Implant Presence-Triggered Osteonecrosis?
    Giovannacci I, Meleti M, Manfredi M, Mortellaro C, Greco Lucchina A, Bonanini M, Vescovi P.
    J Craniofac Surg; 2016 May 01; 27(3):697-701. PubMed ID: 27092912
    [Abstract] [Full Text] [Related]

  • 3. Clinical features of peri-implant medication-related osteonecrosis of the jaw: Is there an association to peri-implantitis?
    Troeltzsch M, Cagna D, Stähler P, Probst F, Kaeppler G, Troeltzsch M, Ehrenfeld M, Otto S.
    J Craniomaxillofac Surg; 2016 Dec 01; 44(12):1945-1951. PubMed ID: 27836551
    [Abstract] [Full Text] [Related]

  • 4. Dental implants as risk factors for patients with medication-related osteonecrosis of the jaws (MRONJ).
    Pichardo SEC, van der Hee JG, Fiocco M, Appelman-Dijkstra NM, van Merkesteyn JPR.
    Br J Oral Maxillofac Surg; 2020 Sep 01; 58(7):771-776. PubMed ID: 32631756
    [Abstract] [Full Text] [Related]

  • 5. Medication-related osteonecrosis of the jaw: risk factors in patients under biphosphonate versus patients under antiresorptive-antiangiogenic drugs.
    Ghidini G, Manfredi M, Giovannacci I, Mergoni G, Sarraj A, Mureddu M, Giunta G, Bonanini M, Meleti M, Vescovi P.
    Minerva Stomatol; 2017 Aug 01; 66(4):135-140. PubMed ID: 28497661
    [Abstract] [Full Text] [Related]

  • 6. Medication-related osteonecrosis of the jaw and successful implant treatment in a patient on high-dose antiresorptive medication: A case report.
    Ottesen C, Andersen SWM, Jensen SS, Kofod T, Gotfredsen K.
    Clin Exp Dent Res; 2022 Oct 01; 8(5):1059-1067. PubMed ID: 35894761
    [Abstract] [Full Text] [Related]

  • 7. The effect of antiresorptive drugs on implant therapy: Systematic review and meta-analysis.
    Stavropoulos A, Bertl K, Pietschmann P, Pandis N, Schiødt M, Klinge B.
    Clin Oral Implants Res; 2018 Oct 01; 29 Suppl 18():54-92. PubMed ID: 30306695
    [Abstract] [Full Text] [Related]

  • 8. Is it safe to place implants in patients at risk of MRONJ?
    Owen B, Bradley H.
    Evid Based Dent; 2021 Jan 01; 22(3):108-109. PubMed ID: 34561663
    [Abstract] [Full Text] [Related]

  • 9. Peri-implantitis-like medication-related osteonecrosis of the jaw: Clinical considerations and histological evaluation with confocal laser scanning microscope.
    Tempesta A, Capodiferro S, Mauceri R, Lauritano D, Maiorano E, Favia G, Limongelli L.
    Oral Dis; 2022 Sep 01; 28(6):1603-1609. PubMed ID: 33844402
    [Abstract] [Full Text] [Related]

  • 10. Dental Implant Placement in Patients With a History of Medications Related to Osteonecrosis of the Jaws: A Systematic Review.
    Sher J, Kirkham-Ali K, Luo JD, Miller C, Sharma D.
    J Oral Implantol; 2021 Jun 01; 47(3):249-268. PubMed ID: 32699903
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Success Rate and Safety of Dental Implantology in Patients Treated With Antiresorptive Medication: A Systematic Review.
    Papadakis I, Spanou A, Kalyvas D.
    J Oral Implantol; 2021 Apr 01; 47(2):169-180. PubMed ID: 32663267
    [Abstract] [Full Text] [Related]

  • 13. Outcome of healing after dental implant placement in patients with cancer on high-dose antiresorptive medications: a prospective feasibility study.
    Andersen SWM, Ottesen C, Gotfredsen K, Jensen SS, Kofod T, Schiodt M.
    Oral Maxillofac Surg; 2023 Mar 01; 27(1):89-100. PubMed ID: 35084584
    [Abstract] [Full Text] [Related]

  • 14. Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases.
    Grant BT, Amenedo C, Freeman K, Kraut RA.
    J Oral Maxillofac Surg; 2008 Feb 01; 66(2):223-30. PubMed ID: 18201600
    [Abstract] [Full Text] [Related]

  • 15. Is medication related osteonecrosis of the jaw around implants a rare entity? A case series with a focus on etiopathophysiology.
    Massaad J, Magremanne M.
    J Stomatol Oral Maxillofac Surg; 2022 Nov 01; 123(6):e743-e748. PubMed ID: 34922047
    [Abstract] [Full Text] [Related]

  • 16. Emerging antiresorptive medications and their potential implications for dental surgeries.
    Aminoshariae A, Donaldson M, Horan M, Mackey SA, Kulild JC, Baur D.
    J Am Dent Assoc; 2022 Jul 01; 153(7):649-658. PubMed ID: 35277242
    [Abstract] [Full Text] [Related]

  • 17. Surgical therapy for medication-related osteonecrosis of the jaw in osteoporotic patients treated with antiresorptive agents.
    Hauer L, Jambura J, Hrusak D, Chalupova M, Posta P, Rusnak S, Vyskocil V.
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Mar 01; 164(1):100-107. PubMed ID: 30647474
    [Abstract] [Full Text] [Related]

  • 18. Medication-Related Osteonecrosis of the Jaws in the Pediatric Population.
    Neal TW, Schlieve T.
    J Oral Maxillofac Surg; 2022 Oct 01; 80(10):1686-1690. PubMed ID: 35931181
    [Abstract] [Full Text] [Related]

  • 19. Medication-Related Osteonecrosis of the Jaw Subsequent to Peri-Implantitis: A Case Report and Literature Review.
    Seki K, Namaki S, Kamimoto A, Hagiwara Y.
    J Oral Implantol; 2021 Dec 01; 47(6):502-510. PubMed ID: 33270837
    [Abstract] [Full Text] [Related]

  • 20. Effect of Antiresorptive Drugs on Osseointegrated Dental Implants: A Systematic Review.
    Li JTW, Leung YY.
    J Clin Med; 2024 Apr 03; 13(7):. PubMed ID: 38610856
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.